The Pennant Group, Inc. (NASDAQ:PNTG) Stock Holdings Increased by Van Berkom & Associates Inc.

Van Berkom & Associates Inc. raised its holdings in shares of The Pennant Group, Inc. (NASDAQ:PNTG) by 2,635.6% in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,198,216 shares of the company’s stock after buying an additional 2,117,859 shares during the period. Van Berkom & Associates Inc. owned about 0.06% of The Pennant Group worth $58,297,000 as of its most recent SEC filing.

Several other hedge funds have also recently added to or reduced their stakes in the business. Quarry LP lifted its position in shares of The Pennant Group by 371.6% during the 3rd quarter. Quarry LP now owns 1,014 shares of the company’s stock valued at $36,000 after acquiring an additional 799 shares during the last quarter. Point72 Asia Singapore Pte. Ltd. raised its position in shares of The Pennant Group by 460.2% during the third quarter. Point72 Asia Singapore Pte. Ltd. now owns 3,311 shares of the company’s stock worth $118,000 after purchasing an additional 2,720 shares during the period. Intech Investment Management LLC purchased a new stake in shares of The Pennant Group during the third quarter valued at $232,000. Summit Global Investments purchased a new stake in shares of The Pennant Group during the third quarter valued at $254,000. Finally, HighTower Advisors LLC purchased a new position in The Pennant Group in the 3rd quarter worth about $282,000. Institutional investors and hedge funds own 85.88% of the company’s stock.

Analysts Set New Price Targets

Several analysts have issued reports on PNTG shares. Truist Financial cut their price objective on The Pennant Group from $38.00 to $32.00 and set a “hold” rating on the stock in a report on Monday, January 6th. Oppenheimer boosted their price target on shares of The Pennant Group from $34.00 to $37.00 and gave the company an “outperform” rating in a report on Friday, November 8th. Finally, Wells Fargo & Company began coverage on shares of The Pennant Group in a research note on Thursday, December 19th. They issued an “equal weight” rating and a $33.00 price objective for the company. Two analysts have rated the stock with a hold rating and three have given a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $36.00.

The Pennant Group Price Performance

NASDAQ PNTG opened at $25.76 on Friday. The company has a debt-to-equity ratio of 0.58, a current ratio of 1.12 and a quick ratio of 1.12. The firm has a market capitalization of $884.86 million, a price-to-earnings ratio of 37.88, a price-to-earnings-growth ratio of 2.35 and a beta of 1.91. The company has a 50 day simple moving average of $27.01 and a 200-day simple moving average of $30.70. The Pennant Group, Inc. has a 52-week low of $16.14 and a 52-week high of $37.13.

The Pennant Group Profile

The Pennant Group, Inc provides healthcare services in the United States. It operates in two segments, Home Health and Hospice Services, and Senior Living Services. The company offers home health services, including clinical services, such as nursing, speech, occupational and physical therapy, medical social work, and home health aide services; and hospice services comprising clinical care, education, and counseling services for the physical, spiritual, and psychosocial needs of terminally ill patients and their families.